EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 29-Apr-2025 15:08 ET (29-Apr-2025 19:08 GMT/UTC)

ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

ECOG-ACRIN Cancer Research Group
Business Announcement

The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) announces new appointments of cancer researchers to lead committees in its expansive scientific program. ECOG-ACRIN is at the forefront of research spanning the cancer care spectrum, from early detection to management of advanced disease. These impactful appointments, which are effective immediately, underscore the group’s commitment to wide-ranging cancer research excellence and premier professional opportunities for researchers.

Four Würzburg researchers are “Highly Cited”

University of Würzburg
Grant and Award Announcement

Once again, several researchers from the University of Würzburg are among the “Highly Cited Researchers”. In 2024, four professors make the list. Their work is frequently cited by colleagues worldwide.

How cancer cells adapt while moving across tissues

Indian Institute of Science (IISc)
Peer-Reviewed Publication

Study shows how inherent variations in a cancer cell and its interactions with its surroundings mould its migration

Journal: Biophysical Journal

Scientists identify key mechanism in development of skin cancer

Ludwig-Maximilians-Universität München
Peer-Reviewed Publication

LMU researchers have discovered how the interplay between a key protein and an endolysosomal ion channel promotes tumor development in skin cancer.

Journal: Nature Communications

The tissue and circulating cell-free DNA-derived genetic landscape of pre-malignant colorectal lesions and its application for early diagnosis of colorectal cancer

Sichuan International Medical Exchange and Promotion Association
Peer-Reviewed Publication

In a paper published in MedComm, authors present evidence of convincing biomarkers for detecting colorectal adenomas with a propensity for colorectal cancer development, highlighting the importance of early genetic screening in colorectal cancer prevention. The genetic alterations of colorectal adenomas were compared with CRC patients from the ChangKang Project.

Journal: MedComm

From food crops to cancer clinics: Lessons in extermination resistance

Arizona State University
Peer-Reviewed Publication

In a new review, Arizona State University researchers, working with colleagues around the world, explore how established agricultural pest management strategies could be adapted to address cancer therapy. The pioneering method opens new possibilities for controlling drug resistance and improving patient survival.

Journal: Cancer Research

Cetuximab outperforms durvalumab in treatment of head and neck cancers

University of California - San Diego
Peer-Reviewed Publication

The standard treatment for head and neck cancer, cisplatin, can’t be given to some patients due to pre-existing conditions. A new study compares the efficacy of two alternatives: cetuximab, a monoclonal antibody, and durvalumab, an immune checkpoint inhibitor.

Journal: The Lancet Oncology

Mass General Brigham and BIDMC researchers unveil an AI protein engineer capable of making proteins ‘better, faster, stronger’

Mass General Brigham
Peer-Reviewed Publication

KEY TAKEAWAYS

Engineered proteins are critical industrial and medical applications, ranging from vaccine development to making crops or food proteins more resilient.

Scientists can engineer proteins to improve upon nature, but such experiments are time- and labor-intensive.

Researchers have developed an AI-based protein design tool known as EVOLVEPro, which is already showing promise for several applications and could be used to help solve other medical challenges.

Journal: Science
Funder: NIH/National Institutes of Health, K. Lisa Yang and Hock E. Tan Center for Molecular Therapeutics in Neuroscience, Impetus Grants, Cystic Fibrosis Foundation Pioneer Grant, Google Ventures, Pivotal Life Sciences, MGB Gene and Cell Therapy Institute, Yosemite Fund, JSPS KAKENHI, Takeda Medical Research Foundation, Inamori Research Institute for Science, JST-Mirai Program, CREST

Study reveals how deadly brain tumor evades treatment; identifies potential new treatment strategy

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

A UCLA study helps explain why glioblastoma, one of the most aggressive forms of brain cancer, becomes resistant to treatment, and introduces a new approach that paves the way for more personalized treatment strategies for patients with this deadly brain tumor.

Journal: Nature Communications
Funder: NIH/National Institutes of Health, Sheila and Stanford L. Kurland Family Foundation, National Brain Tumor Society, Uncle Kory Foundation, Ziering Family Foundation, The Bloomfield Foundation

Scientists implicate a novel cellular protein in hepatitis A infection

University of North Carolina Health Care
Peer-Reviewed Publication

Scientists have long been trying to tease apart hepatitis A virus, to understand its inner workings and how it functions in the human body. Infectious disease researchers at the UNC School of Medicine have discovered that a little-known protein, PDGFA-associated protein 1 (PDAP1), is used as a pawn by hepatitis A virus to replicate and infect cells in the liver.

Journal: Science Advances